Iverson Genetic Diagnostics

Iverson Genetic Diagnostics provides physicians with genetic diagnostic tools for disease detection and informed treatment purposes.

Iverson Genetic Diagnostics, Inc. provides diagnostic tools to prevent and treat chronic diseases for physicians. It develops genetic tests for disease detection and treatment. The company also provides warfarin dosing panel that tests for variations in enzymes that can significantly affect warfarin response; and high risk HPV panel, a screening test that detects various HPVs. In addition, it offers MTHFR assay that detects key variants in the metabolism of homocysteine that are associated with coronary artery disease, thrombosis, heart attacks, and strokes. The company was founded in 2007 and is based in Bothell, Washington.